Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam

Molecular Pharmaceutics

Volumn 6, Issue 3, 2009, Pages 940-950

  Prajapati, Ram N ^a   Tekade, Rakesh K ^a   Gupta, Umesh ^a   Gajbhiye, Virendra ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Dendrimers; Formulation development; Piroxicam; Solubilization

Indexed keywords

ALBUMIN; DENDRIMER; NANOCOMPOSITE; PIROXICAM; POLYAMIDOAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG RELEASE; DRUG SOLUBILITY; ELECTRON MICROSCOPY; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PAW EDEMA; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; DENDRIMERS; EDEMA; ERYTHROCYTES; HEMOLYSIS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; PIROXICAM; RATS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 67249135321     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp8002489     Document Type: Article

References (41)

1. Adjei, A.; Newbuger, J.; Starachansky, S.; Martin, A. Membrane solubility parameter and in-situ release of theophylline. J. Pharm. Sci. 1984, 73, 742-745. (Pubitemid 14122784)
2. Linares, M.; De Bertorello, M. M.; Longhi, M. Solubilization of naphthoquinones by complexation with hydroxypropyl-beta cyclodextrin. Int. J. Pharm. 1997, 159, 13-18. (Pubitemid 28062805)
3. Choi, H. G.; Kim, D. D.; Jun, H. W.; Yoo, B. K.; Yong, C. S. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-cyclodextrin. Drug Dev. Ind. Pharm. 2003, 29, 1085-1094. (Pubitemid 37499544)
4. Liu, M.; Frechet, J. M. J. Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 1999, 2, 393-401. (Pubitemid 29452933)
5. Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Reck, J.; Ryder, J.; Smith, P. A new class of polymers: starburst-dendritic macromolecules. Polym. J. 1985, 17, 117-132.
6. Khalil, S. A.; Martin, A. N. Drug transport though model membrane and its correlation solubility parameter. J. Pharm. Sci. 1967, 56, 1225-1233.
7. Gupta, U.; Agashe, H. B.; Asthana, A.; Jain, N. K. Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement. Biomacromolecules 2006, 7, 649-1648
8. Hawker, C. J.; Wooley, K. L.; Frechet, J. M. J. Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents. J. Chem. Soc., Perkin Trans. 1993, 1, 1287-1297.
9. Milhem, O. M.; Myles, C.; McKeown, N. B.; D'Emanuele, A. Polyamidoamine Starburst dendrimers as solubility enhancers. Int. J. Pharm. 2000, 197, 239-241. (Pubitemid 30125795)
10. Devarakonda, B.; Hill, R. A.; Liebenberg, W.; Brits, M.; De Villiers, M. M. Comparision of aqueous solubilization of practically insoluble niclosamide by polyamidoamone (PAMAM) dendrimers and cyclodextrins. Int. J. Pharm. 2005, 300, 193-209. (Pubitemid 41427662)
11. Devarakonda, B.; Hill, R. A.; De Villiers, M. M. The effect of PAMAM dendrimer generation size and surface functional groups on the aqueous solubility of nifedipine. Int. J. Pharm. 2004, 284, 133-140. (Pubitemid 39349146)
12. Gupta, U.; Agashe, H. A.; Jain, N. K. Polypropylene Imine Dendrimer Mediated Solubility Enhancement: Effect of pH and Functional Groups of Hydrophobes. J. Pharm. Pharm. Sci. 2007, 10, 358-367.
13. Gajbhiye, V.; Kumar, P. V.; Tekade, R. K.; Jain, N. K. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist. Eur. J. Med. Chem. 2009, 44 (3), 1155-1166.
14. Twomey, T. M.; Banolucci, S. R.; Hobbs, D. C. Analysis of piroxicam in plasma by high-performance liquid chromatography. J. Chomatogr. 1980, 183, 104-108. (Pubitemid 11242686)
15. Chi, S. C.; Jun, H. W. Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats. J. Pharm. Sci. 1990, 79, 974-977. (Pubitemid 20376188)
16. Lin, S. Z.; Wouessidijewe, D.; Poelman, M. C.; Duchone, D. In vivo evaluation of indomethacin/cyclodextrin complex: gastrointestinal tolerance and dermal anti-inflammatory activity. Int. J. Pharm. 1994, 106, 63-67. (Pubitemid 24110065)
17. Martinadale: The Complete Drug Reference, 34th ed.; Pharmaceutical Press: London, 2005; p 84.
18. Charumanee, S.; Okonki, S.; Sirithunyalug, J. Improvement of the dissolution rate of piroxicam by surface dispersion. CMU J. 2004, 3, 77-84.
19. Florey, K. Analytical Profile of Drug Substance Academic press, an Imprint of Elsevier: 2005; Vol.15, pp 511-531; 1st Indian print.
20. Tomalia, D. A.; Naylor, A. M.; Goddard, W. A., III. Starburst dendrimers: molecular level control of size, shape, surface chemistry, topology and flexibility from atoms to macroscopic matter. Angew Chem., Int. Engl. 1990, 29, 138-175. (Pubitemid 20142204)
21. Asthana, A.; Chauhan, A. S.; Diwan, P. V.; Jain, N. K. Poly (amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of anti-inflammatory active ingredient. AAPS PharmSciTech 2005, 6, E536-E542.
22. Dutta, T.; Aghase, H. B.; Vijayarajkumar, P.; Joshi, M.; Jain, N. K. Dendrosome-based gene delivery. J. Exp. Nanosci. 2006, 1, 235-248.
23. Tekade, R. K.; Dutta, T.; Gajbhiye, V.; Jain, N. K. Exploring Dendrimer towards Dual Drug Delivery: pH Responsive Simultaneous Drug-Release Kinetics. J. Microencapsulation 2008. DOI, 10.1080/02652040802312572.
24. Higuchi, T.; Connors, A. Phase-solubility techniques. In Advances in Analytical Chemistry and Instrument; Reilly, C. N., Ed.; John Wiley: New York, 1965; pp 117-212.
25. Singhai, A. K.; Jain, S.; Jain, N. K. Evaluation of an aqueous injection of ketoprofen. Pharmazie 1997, 52, 149-151. (Pubitemid 27101347)
26. Vijayaraj kumar, P.; Asthana, A.; Dutta, T.; Jain, N. K. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J. Drug Targeting 2006, 14, 546-556.
27. Brownlee, G. Effect of deoxycortone and ascorbic acid on formaldehyde-induced arthitis in normal and adrenalectomized rats. Lancet 1950, 1, 157.
28. Turner R. A. Screening Methods in Pharmacology; Academic Press: New York, 1965; p 152.
29. Swingle, K. F. Evaluation of Anti-Inflammatory Activity in Anti- Inflammatory Agents; Academic Press: New York, 1974; p 33.
30. Chauhan, A. S.; Jain, N. K.; Diwan, P. V.; Khopade, A. J. Solubility enhancement of indomethacin with poly (amidoamine) dendrimers and targeting to inflammatory regions of arthitis rats. J. Drug Targeting 2004, 12, 575-583. (Pubitemid 40100705)
31. Satyavati, G. V.; Prasad, D. N.; Das, P. K.; Singh, H. D. Antiinflammatory activity of Semecarpus anacaradium linn. Int. J. Physiol. Pharmacol. 1969, 13, 37.
32. Newbould, B. B. Chemotherapy of arthitis induced in rats by mycobacterial adjuvant. Br. J. Pharmacol. Chemother. 1963, 21, 127.
33. Amanlou, M.; Dehpour, A. R. Rapid method for the determination of piroxicam in rat plasma using high-performance liquid chromatography. J. Chomatogr. B 1997, 696, 317-319. (Pubitemid 27387460)
34. Manuela, T. M.; Joao, P. P.; Jose, A. M. A rapid method for the determination of piroxicam in plasma by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 1995, 13, 319-322.
35. Chauhan, A. S.; Sridevi, S.; Chalasani, K. B.; Jain, A. K.; Jain, S. K.; Jain, N. K.; Diwan, P. V. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J. Controlled Release 2003, 90, 335-343. (Pubitemid 36869009)
36. Beezer, A. E.; King, A. S. H.; Martin, I. K.; Mitchel, J. C.; Twyman, L. J.; Wain, C. F. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM dendrimers. Tetrahedron 2003, 59, 3873-3880. (Pubitemid 36577607)
37. Tekade, R. K.; Dutta, T.; Tyagi, A.; Bharti, A. C.; Das, B. C.; Jain, N. K. Surface Engineered Dendrimers For Dual Drug Delivery: A Receptor Up-regulation and Enhanced Cancer Targeting Strategy. J. Drug Targeting 2008, 16, 758-772.
38. Wunder, A.; Muller-Lader, U.; Steler, E. H. K.; Funk, J.; Neumann, E.; Stechle, G.; Pap, T.; Sinn, H.; Gay, S.; Fiehn, C. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthitis. J. Immunol. 2003, 170, 4793-4801. (Pubitemid 36519989)
39. Goodman, L. S.; Gilman, A. G.; Rall, T. W.; Murad F. The Pharmacological Basis of Therapeutics, 10th ed.; McGraw-Hill Health Profession Div.: New York, 2001; pp 670-680, 713-714.
40. Winalski, C. S.; Shortkroff, S.; Mulkern, R. V.; Schneider, E.; Rosen, G. M. Magnetic resonance relaxivity of dendrimer-linked nitroxides. Magn. Reson. Med. 2002, 48, 965-972. (Pubitemid 35398525)
41. Tekade, R. K.; Vijayarajkumar, P.; Jain, N. K. Dendrimers in oncology: An expanding horizon. Chem. Rev. 2008, 109, 49-87.